- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 64.24M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $202.01M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $187.03M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $589.16M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $630.22M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.59B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.63B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $732.65M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $786.11M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.64B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.65B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $334.69M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $198.72M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 74.02M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $620K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $31.07M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | −$86.39M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$118.18M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $0.02 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $0.02 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $19.93M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $41.37M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | $1.41M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $9.72M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $144.11M |
| Revenue | Q1 2025 · Mar 31, 2024 | $205.1M |